The AKT inhibitor capivasertib (AZD5363): from discovery to clinical proof concept – Dr Barry Davies, Director, Clinical Translation Scientific Alliances, AstraZeneca

When:
February 11, 2021 @ 9:30 am – 10:30 am
2021-02-11T09:30:00+00:00
2021-02-11T10:30:00+00:00
Where:
Online
Google Meet
Contact:
Justin Holt

Abstract not available

Leave a Reply

Your email address will not be published. Required fields are marked *